Tissue‐Targeted Drug Delivery Strategies to Promote Antigen‐Specific Immune Tolerance

Y Rui, HB Eppler, AA Yanes… - Advanced healthcare …, 2023 - Wiley Online Library
During autoimmunity or organ transplant rejection, the immune system attacks host or
transplanted tissue, causing debilitating inflammation for millions of patients. There is no …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] Tissue-targeted drug delivery strategies to promote antigen-specific immune tolerance

Y Rui, HB Eppler, AA Yanes… - Advanced healthcare …, 2023 - ncbi.nlm.nih.gov
During autoimmunity or organ transplant rejection, the immune system attacks host or
transplanted tissue, causing debilitating inflammation for millions of patients. There is no …

Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.

Y Rui, HB Eppler, AA Yanes… - Advanced Healthcare …, 2022 - europepmc.org
During autoimmunity or organ transplant rejection, the immune system attacks host or
transplanted tissue, causing debilitating inflammation for millions of patients. There is no …

Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance

Y Rui, HB Eppler, AA Yanes, CM Jewell - 2022 - drum.lib.umd.edu
During autoimmunity or organ transplant rejection, the immune system attacks host or
transplanted tissue, causing debilitating inflammation for millions of patients. There is no …

Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance

Y Rui, HB Eppler, AA Yanes… - Advanced healthcare …, 2023 - pubmed.ncbi.nlm.nih.gov
During autoimmunity or organ transplant rejection, the immune system attacks host or
transplanted tissue, causing debilitating inflammation for millions of patients. There is no …

Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.

Y Rui, HB Eppler, AA Yanes… - Advanced Healthcare …, 2022 - europepmc.org
During autoimmunity or organ transplant rejection, the immune system attacks host or
transplanted tissue, causing debilitating inflammation for millions of patients. There is no …